Sicco Anthony Bus

Prof. Dr. Sicco Anthony Bus

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2020 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Open access
PDF file
NSNicolaas Schaper
Nicolaas Schaper
JNJaap J. Van Netten
Jaap J. Van Netten
JAJan Apelqvist
Jan Apelqvist
SBSicco Anthony Bus
Sicco Anthony Bus
RHRobert J. Hinchliffe
Robert J. Hinchliffe
IBIWGDF Editorial Board
IWGDF Editorial Board
Diabetic foot disease results in a major global burden for patients and the health care system. The International Working Group on the Diabetic Foot (IWGDF) has been producing evidence‐based guidelines on the prevention and management of diabetic foot disease since 1999. In 2019, all IWGDF Guidelines have been updated based on systematic reviews of the literature and formulation of recommendations by multidisciplinary experts from all over the world.In this document, the IWGDF Practical Guidelines, we describe the basic principles of prevention, classification, and treatment of diabetic foot disease, based on the six IWGDF Guideline chapters. We also describe the organizational levels to successfully prevent and treat diabetic foot disease according to these principles and provide addenda to assist with foot screening. The information in these practical guidelines is aimed at the global community of health care professionals who are involved in the care of persons with diabetes.Many studies around the world support our belief that implementing these prevention and management principles is associated with a decrease in the frequency of diabetes‐related lower extremity amputations. We hope that these updated practical guidelines continue to serve as reference document to aid health care providers in reducing the global burden of diabetic foot disease.

27 May 2023 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Open access
NSNicolaas C. Schaper
Nicolaas C. Schaper
JNJaap J. Van Netten
Jaap J. Van Netten
JAJan Apelqvist
Jan Apelqvist
SBSicco Anthony Bus
Sicco Anthony Bus
RFRobert Fitridge
Robert Fitridge
TBthe IWGDF Editorial Board
the IWGDF Editorial Board
Diabetes‐related foot disease results in a major global burden for patients and the healthcare system. The International Working Group on the Diabetic Foot (IWGDF) has been producing evidence‐based guidelines on the prevention and management of diabetes‐related foot disease since 1999. In 2023, all IWGDF Guidelines have been updated based on systematic reviews of the literature and formulation of recommendations by multidisciplinary experts from all over the world. In addition, a new guideline on acute Charcot neuro‐osteoarthropathy was created. In this document, the IWGDF Practical Guidelines, we describe the basic principles of prevention, classification and management of diabetes‐related foot disease based on the seven IWGDF Guidelines. We also describe the organisational levels to successfully prevent and treat diabetes‐related foot disease according to these principles and provide addenda to assist with foot screening. The information in these practical guidelines is aimed at the global community of healthcare professionals who are involved in the care of persons with diabetes. Many studies around the world support our belief that implementing these prevention and management principles is associated with a decrease in the frequency of diabetes‐related lower‐extremity amputations. The burden of foot disease and amputations is increasing at a rapid rate, and comparatively more so in middle to lower income countries. These guidelines also assist in defining standards of prevention and care in these countries. In conclusion, we hope that these updated practical guidelines continue to serve as a reference document to aid healthcare providers in reducing the global burden of diabetes‐related foot disease.

16 March 2020 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Open access
PDF file
SBSicco Anthony Bus
Sicco Anthony Bus
LLLawrence A. Lavery
Lawrence A. Lavery
Matilde Monteiro-SoaresMatilde Monteiro-Soares
Matilde Monteiro-Soares
ARAnne Rasmussen
Anne Rasmussen
ARAnita Raspovic
Anita Raspovic
OFon behalf of the International Working Group on the Diabetic Foot
on behalf of the International Working Group on the Diabetic Foot
The International Working Group on the Diabetic Foot (IWGDF) has published evidence‐based guidelines on the prevention and management of diabetic foot disease since 1999. This guideline is on the prevention of foot ulceration in persons with diabetes and updates the 2015 IWGDF prevention guideline. We followed the GRADE methodology to devise clinical questions and critically important outcomes in the PICO format, to conduct a systematic review of the medical‐scientific literature, and to write recommendations and their rationale. The recommendations are based on the quality of evidence found in the systematic review, expert opinion where evidence was not available, and a weighing of the benefits and harms, patient preferences, feasibility and applicability, and costs related to the intervention. We recommend to screen a person at very low risk for ulceration annually for loss of protective sensation and peripheral artery disease and persons at higher risk at higher frequencies for additional risk factors. For preventing a foot ulcer, educate the at‐risk patient about appropriate foot self‐care and treat any pre‐ulcerative sign on the foot. Instruct moderate‐to‐high risk patients to wear accommodative properly fitting therapeutic footwear, and consider instructing them to monitor foot skin temperature. Prescribe therapeutic footwear that has a demonstrated plantar pressure relieving effect during walking to prevent plantar foot ulcer recurrence. In patients that fail non‐surgical treatment for an active or imminent ulcer, consider surgical intervention; we suggest not to use a nerve decompression procedure. Provide integrated foot care for high‐risk patients to prevent ulcer recurrence. Following these recommendations will help health care professionals to provide better care for persons with diabetes at risk of foot ulceration, to increase the number of ulcer‐free days, and to reduce the patient and health care burden of diabetic foot disease.

14 January 2020 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Open access
PDF file
JNJaap J. Van Netten
Jaap J. Van Netten
SBSicco Anthony Bus
Sicco Anthony Bus
JAJan Apelqvist
Jan Apelqvist
BLBenjamin A. Lipsky
Benjamin A. Lipsky
RHRobert J. Hinchliffe
Robert J. Hinchliffe
OFon behalf of the International Working Group on the Diabetic Foot
on behalf of the International Working Group on the Diabetic Foot
Multiple disciplines are involved in the management of diabetic foot disease, and a common vocabulary is essential for clear communication. Based on the systematic reviews of the literature that form the basis of the International Working Group on the Diabetic Foot (IWGDF) Guidelines, the IWGDF has developed a set of definitions and criteria for diabetic foot disease. This document describes these definitions and criteria. We suggest these definitions be used consistently in both clinical practice and research to facilitate clear communication between professionals.

26 January 2016 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
PDF file
SBSicco Anthony Bus
Sicco Anthony Bus
JNJaap J. Van Netten
Jaap J. Van Netten
LLL. A. Lavery
L. A. Lavery
Matilde Monteiro-SoaresMatilde Monteiro-Soares
Matilde Monteiro-Soares
ARA. Rasmussen
A. Rasmussen
O(on behalf of the International Working Group on the Diabetic Foot (IWGDF)
on behalf of the International Working Group on the Diabetic Foot (IWGDF)

11 June 2023 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Open access
SBSicco Anthony Bus
Sicco Anthony Bus
ISIsabel C. N. Sacco
Isabel C. N. Sacco
Matilde Monteiro-SoaresMatilde Monteiro-Soares
Matilde Monteiro-Soares
ARAnita Raspovic
Anita Raspovic
JPJoanne Paton
Joanne Paton
JNJaap J. Van Netten
Jaap J. Van Netten
Aims: This is the 2023 International Working Group on the Diabetic Foot guideline on the prevention of foot ulcers in persons with diabetes, which updates the 2019 guideline. This guideline is targeted at clinicians and other healthcare professionals.Materials and Methods: We followed the Grading of Recommendations, Assessment, Development and Evaluations methodology to devise clinical questions and critically important outcomes in the PICO format, to conduct a systematic review of the medical‐scientific literature including, where appropriate, meta‐analyses, and to write recommendations and their rationale. The recommendations are based on the quality of evidence found in the systematic review, expert opinion where (sufficient) evidence was not available, and a weighing of the desirable and undesirable effects of an intervention, as well as patient preferences, costs, equity, feasibility and applicability.Results: We recommend screening a person with diabetes at very low risk of foot ulceration annually for the loss of protective sensation and peripheral artery disease, and screening persons at higher risk at higher frequencies for additional risk factors. For preventing a foot ulcer, educate persons at‐risk about appropriate foot self‐care, educate not to walk without suitable foot protection, and treat any pre‐ulcerative lesion on the foot. Educate moderate‐to‐high risk people with diabetes to wear properly fitting, accommodative, therapeutic footwear, and consider coaching them to monitor foot skin temperature. Prescribe therapeutic footwear that has a demonstrated plantar pressure relieving effect during walking, to help prevent plantar foot ulcer recurrence. Consider advising people at low‐to‐moderate risk to undertake a, preferably supervised, foot‐ankle exercise programme to reduce ulcer risk factors, and consider communicating that a total increase in weight‐bearing activity of 1000 steps/day is likely safe with regards to risk of ulceration. In people with non‐rigid hammertoe with pre‐ulcerative lesion, consider flexor tendon tenotomy. We suggest not to use a nerve decompression procedure to help prevent foot ulcers. Provide integrated foot care for moderate‐to‐high‐risk people with diabetes to help prevent (recurrence of) ulceration.Conclusions: These recommendations should help healthcare professionals to provide better care for persons with diabetes at risk of foot ulceration, to increase the number of ulcer‐free days and reduce the patient and healthcare burden of diabetes‐related foot disease.